Equistatin from sea anemone is a protein composed of three thyroglobulin-type 1 domains known to inhibit papain-like cysteine proteinases, papain, and cathepsins B and L. Limited proteolysis was used to dissect equistatin into a first domain, eq d-1, and a combined second and third domain, eq d-2,3. Only the N-terminal domain inhibits papain (K i ؍ 0.61 nM). Remarkably, equistatin also strongly inhibits cathepsin D with K i ؍ 0.3 nM but not other aspartic proteinases such as pepsin, chymosin, and HIV-PR. This activity resides on the eq d-2,3 domains (K i ؍ 0.4 nM). Papain and cathepsin D can be bound and inhibited simultaneously by equistatin at pH 4.5, confirming the physical separation of the two binding sites. Equistatin is the first inhibitor of animal origin known to inhibit cathepsin D. The obtained results demonstrate that the widely distributed thyroglobulin type-1 domains can support a variety of functions.The recently discovered thyroglobulin type-1 domain inhibitors, thyropins, are a group of proteins that have the ability to inhibit both cysteine (1) and a group of as yet uncharacterized cation-dependent proteinases (2). Thyroglobulin type-1 domain is a structural element first found in thyroglobulin, a molecule that serves as the precursor of the thyroid hormone and in which three different types of cysteine-rich domains are present (3). This domain is exclusively present on the N-terminal section and is repeated 11 times (4). Similar type-1 domains, recognizable by the sequence motif of Cys-Trp-Cys-Val, have been found in many other proteins including saxiphilin (5, 6), nidogen (7), insulin-like growth factor-binding proteins (8), pancreatic carcinoma marker proteins (GA-733) (9), testican (10), major histocompatibility complex class II-associated p41 invariant chain (11), chum salmon egg cysteine proteinase inhibitor (ECI) 1 (12), and equistatin (13,14). In these proteins (except ECI and equistatin) the type-1 domain represents only part of the molecule. The function of these repetitive sequences is unknown, although there is evidence that the type-1 domain itself can act as an inhibitor of cysteine proteinases, as shown in equistatin, ECI, and p41 fragment (11)(12)(13)(14)(15).Equistatin is a protein isolated from sea anemone Actinia equina. It is a reversible and tightly binding competitive inhibitor of papain-like cysteine proteinases. Sequence data (SWISS-PROT accession number P8149) have shown that the inhibitor has an M r of 21,755 and is composed of three repeated thyroglobulin type-1 domains (13,14). The first domain (eq d-1) has 43% sequence identity with the second domain (eq d-2) and 49% with the third domain (eq d-3), whereas eq d-2 and eq d-3 show 32% identity. In the present study we have examined the inhibitory activity of the thyroglobulin type-1 domains present in equistatin. This has been done by dissecting the molecule by limited proteolysis into folded domain structures, isolating the domains and investigating their inhibitory activities against the cysteine proteinase: p...